Opportunity
SAM #36C24526Q0652
Contingency Hazardous Chemotherapy Compounding Services for VA Medical Center
Buyer
VA Network Contracting Office 5
Posted
July 30, 2026
Respond By
August 14, 2026
Identifier
36C24526Q0652
NAICS
325412, 621610
This opportunity is for contingency hazardous chemotherapy compounding services to support the Louis A. Johnson VA Medical Center in Clarksburg, West Virginia, ensuring uninterrupted patient care if the facility's IV pharmacy room is unavailable. - Government Buyer: - Department of Veterans Affairs, VA Maryland Health Care System - Office: Contracting Officer (19ACQ) - Services Requested: - On-demand, patient-specific hazardous chemotherapy compounding - Includes aseptic compounding, chemotherapy drug supply, ancillary supplies (CSTDs, tubing, bags), and shipping - All services must comply with FDA 503A and USP 797/800 standards - Products/Line Items: - Compounded Dose Labor Fee (per patient order) - Chemotherapy Drug Supply (billed per actual medication used) - Ancillary Supplies (closed system transfer devices, tubing, bags, etc.) - Shipping & Delivery (including cold chain transport) - Contract Structure: - Fixed price, 5-year Indefinite Delivery Indefinite Quantity (IDIQ) contract - Base year plus four option years - Minimum guarantee: $300; contract ceiling: $349,000 - Unique Requirements: - Contractor must provide all compounding and delivery services on a contingency basis if the medical center's IV room is non-operational - Adherence to strict regulatory and safety standards is mandatory - No specific OEMs or named vendors are identified in the solicitation
Description
Fixed Price 5-year Indefinite Delivery Indefinite Quantity (IDIQ) solicitation for contingency hazardous chemotherapy compounding services in the event the Louis A. Johnson VA Medical Center (LAJVAMC), Inpatient Pharmacy intravenous (IV) room becomes non-operational. Additional Links:Home Page